Medicines Australia welcomes the recommendations of an independent review into the Therapeutic Goods Administration (TGA) which, if adopted, will help to cut time delays and improve Australian’s access to new, innovative medicines.

The review examined the TGA’s regulatory framework and processes with a view to identifying areas of unnecessary red tape and opportunities to enhance and streamline the regulatory framework.

Medicines Australia CEO, Tim James, welcomed the report and said the industry is keen to work with the Government to ensure that Australia both maintains and evolves our current world class system.

“It’s pleasing to see that many of the recommendations proposed by Medicines Australia have been adopted in this report,” said Mr James.

“Encouraging work sharing with overseas regulators, accelerated approval pathways and retaining the capacity of the TGA to undertake assessments of therapeutic goods are sensible proposals and it’s good to see that this independent report agrees.”

For more details, go to: https://medicinesaustralia.com.au/media-release/independent-review-of-tga-provides-sensible-solutions-to-accelerate-access-to-new-medicines/